Metagenomi (MGX) Stock Chart & Stock Price History → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free MGX Stock Alerts $6.55 -0.34 (-4.93%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Metagenomi Stock Price Performance5 Day Performance+1.39%1 Month Performance-26.90%3 Month Performance-41.88% Receive MGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metagenomi and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company MGX Stock Chart for Sunday, May, 12, 2024 MGX Chart by TradingView Metagenomi Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$6.89$6.55-4.93%$7.10$6.4265,829 shs$245.43 million05/09/2024$6.80$6.89+1.32%$7.09$6.5934,070 shs$258.17 million05/08/2024$6.46$6.80+5.26%$6.85$6.4141,633 shs$254.80 million05/07/2024$6.47$6.46-0.15%$6.83$6.23182,344 shs$242.06 million05/06/2024$6.32$6.47+2.37%$6.85$6.2257,226 shs$242.43 million05/03/2024$6.17$6.32+2.43%$6.69$6.2268,675 shs$236.81 million Get the Latest News and Ratings for MGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Metagenomi and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$7.04$6.17-12.36%$6.34$5.50982,117 shs$231.19 million05/01/2024$7.02$7.04+0.28%$7.47$7.0088,913 shs$263.79 million04/30/2024$8.10$7.02-13.33%$8.30$6.9886,690 shs$263.04 million04/29/2024$7.53$8.10+7.57%$8.40$7.50125,984 shs$303.51 million04/26/2024$6.74$7.53+11.72%$7.69$6.66139,170 shs$282.15 million04/25/2024$6.75$6.74-0.15%$7.01$6.52357,204 shs$252.55 million04/24/2024$7.03$6.75-3.98%$7.21$6.68149,828 shs$252.92 million04/23/2024$6.68$7.03+5.24%$7.20$6.5051,013 shs$263.41 million04/22/2024$6.89$6.68-3.05%$7.05$6.63118,474 shs$250.30 million04/19/2024$7.75$6.89-11.10%$7.94$6.50182,010 shs$258.17 million04/18/2024$8.25$7.75-6.06%$8.42$7.6799,684 shs$290.39 million04/17/2024$8.27$8.25-0.24%$8.86$8.10146,909 shs$309.14 million04/16/2024$8.54$8.27-3.16%$8.84$8.1290,723 shs$309.88 million04/15/2024$8.96$8.54-4.69%$9.00$8.2994,442 shs$319.99 million04/12/2024$9.44$8.96-5.08%$9.67$8.6995,701 shs$335.75 million04/11/2024$9.40$9.44+0.43%$10.14$9.3683,643 shs$353.72 million04/10/2024$10.42$9.40-9.79%$10.37$9.2889,461 shs$352.22 million04/09/2024$9.84$10.42+5.89%$10.50$9.9448,389 shs$390.44 million04/08/2024$9.83$9.84+0.10%$10.31$9.50105,225 shs$368.71 million04/05/2024$10.09$9.83-2.58%$10.56$9.8291,592 shs$368.33 million04/04/2024$10.49$10.09-3.81%$10.94$10.0573,173 shs$378.07 million04/03/2024$10.26$10.49+2.24%$10.94$10.2594,482 shs$393.06 million04/02/2024$10.82$10.26-5.18%$10.80$10.1571,860 shs$384.44 million04/01/2024$10.55$10.82+2.56%$10.93$10.50152,787 shs$405.43 million03/29/2024$10.55$10.55$11.13$10.48157,116 shs$395.94 million03/28/2024$11.09$10.55-4.87%$11.13$10.48157,108 shs$395.94 million03/27/2024$11.32$11.09-2.03%$11.80$10.92132,985 shs$416.21 million03/26/2024$11.15$11.32+1.52%$11.41$10.96115,614 shs$424.84 million03/25/2024$11.41$11.15-2.28%$11.86$11.0397,119 shs$418.46 million03/22/2024$11.31$11.41+0.88%$11.41$11.0889,555 shs$428.22 million03/21/2024$10.88$11.31+3.95%$11.34$10.7863,604 shs$424.46 million03/20/2024$11.35$10.88-4.14%$11.57$10.7863,591 shs$408.33 million03/19/2024$11.07$11.35+2.53%$11.67$10.9074,037 shs$425.97 million03/18/2024$10.14$11.07+9.17%$11.41$10.0283,204 shs$415.46 million[Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (Ad)Join us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. Click here to register now (5/15 Webinar)03/15/2024$10.72$10.14-5.41%$11.13$9.87467,935 shs$380.55 million03/14/2024$11.08$10.72-3.25%$11.22$10.6079,238 shs$402.30 million03/13/2024$11.44$11.08-3.15%$11.76$10.69105,900 shs$415.81 million03/12/2024$12.00$11.44-4.67%$12.10$11.3992,462 shs$429.34 million03/11/2024$11.78$12.00+1.87%$12.05$11.60199,991 shs$450.36 million03/08/2024$12.00$11.78-1.83%$12.10$11.54146,606 shs$442.10 million03/07/2024$12.00$12.00$12.35$11.82146,542 shs$450.36 million03/06/2024$11.64$12.00+3.09%$12.07$11.64155,133 shs$450.36 million03/05/2024$12.04$11.64-3.32%$12.50$11.51224,337 shs$436.85 million03/04/2024$12.00$12.04+0.33%$12.30$11.83106,361 shs$451.86 million03/01/2024$11.86$12.00+1.18%$12.13$11.76136,612 shs$450.36 million02/29/2024$11.52$11.86+2.95%$11.86$11.3437,370 shs$445.11 million02/28/2024$12.00$11.52-4.00%$12.10$11.3195,010 shs$432.35 million02/27/2024$11.89$12.00+0.93%$12.01$11.44131,902 shs$450.36 million02/26/2024$11.90$11.89-0.08%$12.00$11.41114,904 shs$446.23 million02/23/2024$11.71$11.90+1.62%$12.00$11.70106,112 shs$446.61 million02/22/2024$11.30$11.71+3.63%$12.03$11.40192,372 shs$439.48 million02/21/2024$11.81$11.30-4.32%$11.96$11.10259,119 shs$424.09 million02/20/2024$12.20$11.81-3.20%$12.33$11.77279,655 shs$443.23 million02/19/2024$12.20$12.20$12.39$11.53368,000 shs$457.87 million02/16/2024$12.16$12.20+0.33%$12.39$11.53367,999 shs$0.0002/15/2024$12.25$12.16-0.73%$12.74$11.59392,653 shs$0.0002/14/2024$11.69$12.25+4.79%$12.38$11.03296,729 shs$0.0002/13/2024$11.27$11.69+3.73%$12.30$11.13557,197 shs$0.0002/12/2024$10.31$11.27+9.31%$12.22$10.561.14 million shs$0.00 Related Companies: Fennec Pharmaceuticals Stock Chart Monte Rosa Therapeutics Stock Chart Poseida Therapeutics Stock Chart Sutro Biopharma Stock Chart Coherus BioSciences Stock Chart Agenus Stock Chart Adaptimmune Therapeutics Stock Chart Invivyd Stock Chart Candel Therapeutics Stock Chart Opthea Stock Chart Receive MGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Metagenomi and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MGX) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.